Future Indications definition

Future Indications means any community-acquired indications outside of the Field;
Sample 1Sample 2Sample 3
Future Indications means all treatment, prevention or palliation of Indications other than the Cosmetic Indication and Current Indications.
Sample 1
Future Indications means use of Licensed Product for the treatment of any illness, sickness, interruption, cessation or disorder of a particular bodily function, system or organ except psoriasis and the treatment or prevention of organ transplant rejection. A separate Future Indication will not exist solely on the basis of the severity of the ailment, the frequency or route of any treatment or the demographics of the patient class. For purposes of clarity, rheumatoid arthritis and psoriatic arthritis are each separate Future Indications.
Sample 1

Examples of Future Indications in a sentence

  • Each Party shall review and evaluate proposals for Future Indications in good faith; however, either Party may decline to participate in ("Opt Out" of) the Development of a particular Product in a particular Future Indication in its sole discretion.

  • Alexion shall be solely responsible for package design and trade dress used for Products in the Field in the Territory, except for Products in Future Indications as to which Alexion has Opted Out and not Opted Back In, in which case XOMA shall be solely responsible therefor.

  • Potential Future Indications for AP101In January 2016, Amryt received marketing approval for AP101 for the treatment of PTW in adults from the European Commission.

  • Constructing areaof approximately 31,000 square meters of the hotel building are included inproperty, plant and equipment.

  • Par shall use its Commercially Reasonable Efforts to Commercialize the Product in the Primary UMM Indication, the Secondary UMM Indication and any Future Indications that have obtained Regulatory Approval in the Territory.

  • Upon expiration of this Agreement pursuant to Section 13.1, provided that Alexion has at the time of expiration completed a Phase II Study for a Product in any Future Indication which XOMA has not Opted Back In to prior to such expiration, Alexion shall have an exclusive (even as to XOMA), sublicensable license under the XOMA Technology to use, develop, make, have made, sell, have sold, offer for sale, import and export Products only for such Future Indication(s) in the Territory.

  • Subject to Section 3.7, Alfacell has the sole right to develop the Product for Future Indications.

  • Each Party shall review and evaluate proposals for Future Indications and Organ Transplant Indications in good faith; however, either Party may decline to participate ("Opt-Out") in the development of a proposed Future Indication or Organ Transplant Indication in its sole discretion.

  • The Armed Conflict in West Papua throughout 2021 – Trends, Developments and Future Indications.

  • For Future Indications and Organ Transplant Indications for which Genentech has not opted-in, clinical supplies of Licensed Product will be provided at the Cost of Goods Sold, and the Parties will negotiate a commercial supply agreement, on commercially reasonable terms which shall represent not more than [*].


More Definitions of Future Indications

Future Indications means all treatment, prevention or palliation of Indications other than Cosmetic Indications and Current Indications. For clarity, “Future Indications” includes future therapeutic Indications that GSK or its Affiliate chooses to develop and commercialize in the Territory, including but not limited to the treatment, prevention or palliation of the following: ***. For further clarity, “Future Indications” does not include any future aesthetic Indications that ALLERGAN chooses to develop in the Territory, as further described in the definition of Cosmetic Indication.
Sample 1
Future Indications means all treatment, prevention or palliation of Indications other than Cosmetic Indications and Current Indications. For clarity, “Future Indications” includes future therapeutic Indications that GSK or its Affiliate chooses to develop and commercialize in the Territory, including but not limited to the treatment, prevention or palliation of the following: ***. For further clarity, “Future Indications” does not include any future aesthetic *** Certain confidential information contained in this document, marked with 3 asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Act of 1934, as amended. Indications that ALLERGAN chooses to develop in the Territory, as further described in the definition of Cosmetic Indication.
Sample 1

Related to Future Indications

  • Additional Indication means any indication other than the Initial Indication.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • First Indication means the first disease condition for which a particular Licensed Product has been approved by a Regulatory Authority.

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Second Indication means [***].

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Field means all fields of use.

  • Therapeutically equivalent drug products means drug products that contain the same active

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Existing Product means any formulation of the same product category and form sold, supplied, manufactured, or offered for sale in California prior to the following dates, or any subsequently introduced identical formulation:

  • Initial Indication means the use of a Product for the treatment of opioid addiction.

  • Covered Products means Your Applications, Libraries, Passes, Safari Extensions, Safari Push Notifications, and/or FPS implementations developed under this Agreement.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Additional Product means any Product identified as such in the Product Terms and chosen by Enrolled Affiliate under this Enrollment.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • X-ray field means that area of the intersection of the useful beam and any one of the set of planes parallel to and including the plane of the image receptor, whose perimeter is the locus of points at which the exposure rate is one-fourth of the maximum in the intersection.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Territory means worldwide.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.